Necrostatin-1 blocks both RIPK1 and IDO: consequences for the study of cell death in experimental disease models

Por Vandenabeele, P, Grootjans, S, Callewaert, N, Takahashi, N
Publicado em 2013

Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models

Por Takahashi, N, Duprez, L, Grootjans, S, Cauwels, A, Nerinckx, W, DuHadaway, J B, Goossens, V, Roelandt, R, Van Hauwermeiren, F, Libert, C, Declercq, W, Callewaert, N, Prendergast, G C, Degterev, A, Yuan, J, Vandenabeele, P
Publicado em 2012

Multiple Phenotypes in Phosphoglucomutase 1 Deficiency

Por Tegtmeyer, L.C., Rust, S., van Scherpenzeel, M., Ng, B.G., Losfeld, M.-E., Timal, S., Raymond, K., He, P., Ichikawa, M., Veltman, J., Huijben, K., Shin, Y.S., Sharma, V., Adamowicz, M., Lammens, M., Reunert, J., Witten, A., Schrapers, E., Matthijs, G., Jaeken, J., Rymen, D., Stojkovic, T., Laforêt, P., Petit, F., Aumaître, O., Czarnowska, E., Piraud, M., Podskarbi, T., Stanley, C.A., Matalon, R., Burda, P., Seyyedi, S., Debus, V., Socha, P., Sykut-Cegielska, J., van Spronsen, F., de Meirleir, L., Vajro, P., DeClue, T., Ficicioglu, C., Wada, Y., Wevers, R.A., Vanderschaeghe, D., Callewaert, N., Fingerhut, R., van Schaftingen, E., Freeze, H.H., Morava, E., Lefeber, D.J., Marquardt, T.
Publicado no N Engl J Med (2014)